Health & Behavior

Research

The Latest

UC San Diego Cancer Scientists Named to First Class of AACR Fellows

Five University of California, San Diego scientists and professors are among the first class of the Fellows of the American Association for Cancer Research Academy, created to recognize researchers whose scientific contributions have propelled significant innovation and progress against cancer. The entire class consists of 106 individuals, to celebrate the 106 year anniversary of AACR, the world’s first and largest professional organization dedicated to advancing cancer research.

Monoclonal Antibody Targets, Kills Leukemia Cells

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

UC San Diego Pharmacy School Benefactor “Sam” Skaggs Dies at 89

L.S. “Sam” Skaggs, whose enduring support of pharmacy education and research helped fuel the growth and development of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, died Thursday at the age of 89 of causes related to age.

Kidney Sparing Surgery Underutilized for Patients Who Need It Most

Researchers at the University of California, San Diego School of Medicine have released study results that show national treatment trends in the surgical management of patients with kidney disease. The study found that partial and complete kidney removal (total nephrectomy) and energy-based techniques to destroy tumors are all on the rise. Surprisingly, the patients most in need of kidney-sparing surgery are still more likely to undergo total nephrectomy.

Beyond the Campaign Poster: UC San Diego’s United Way/CHAD Campaign

Every February, posters for UC San Diego’s United Way/CHAD Campaign begin to appear in campus elevators, break-rooms, hallways and offices. Invitations to fundraising events and requests to make a pledge to the campaign follow. For some, that’s where their involvement with the campaign ends.

New Imaging Agent Enables Better Cancer Detection, More Accurate Staging

Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the current standard dye.